EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Dermatologic Clinics
- Vol. 18 (1) , 147-156
- https://doi.org/10.1016/s0733-8635(05)70155-8
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Interleukin-2 fusion protein: An investigational therapy for interleukin-2 receptor expressing malignanciesEuropean Journal Of Cancer, 1997
- Chromosomal Abnormalities in Cutaneous T-Cell Lymphoma and in Its Premalignant Conditions as Detected by G-Banding and Interphase Cytogenetic MethodsJournal of Investigative Dermatology, 1997
- Progression of Mycosis Fungoides Is Associated with Increasing Cutaneous Expression of Interleukin-10 mRNAJournal of Investigative Dermatology, 1996
- The Immune Response to Class I-Associated Tumor-Specific Cutaneous T-Cell Lymphoma AntigensJournal of Investigative Dermatology, 1996
- HLA-DR5 and DQB1*03 Class II Alleles Are Associated With Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 1996
- Combined modality therapy for cutaneous T-cell lymphomaJournal of the American Academy of Dermatology, 1996
- Malignant and Normal T Cells Show Random Use of T-Cell Receptor ∝ Chain Variable Regions in Patients with Cutaneous T-Cell LymphomaJournal of Investigative Dermatology, 1995
- Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantationClinical and Experimental Dermatology, 1995
- Activity of Fludarabine Monophosphate in Patients With Advanced Mycosis Fungoides: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1990
- Mycosis Fungoides in the United StatesPublished by American Medical Association (AMA) ,1988